301 related articles for article (PubMed ID: 16785603)
1. Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease.
Tamás A; Lubics A; Lengvári I; Reglodi D
Endocrine; 2006 Apr; 29(2):275-87. PubMed ID: 16785603
[TBL] [Abstract][Full Text] [Related]
2. Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats.
Tamás A; Lubics A; Szalontay L; Lengvári I; Reglodi D
Behav Brain Res; 2005 Mar; 158(2):221-9. PubMed ID: 15698888
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of the effects of PACAP in young, aging, and castrated males in a rat model of Parkinson's disease.
Reglódi D; Tamás A; Lengvári I; Toth G; Szalontay L; Lubics A
Ann N Y Acad Sci; 2006 Jul; 1070():518-24. PubMed ID: 16888218
[TBL] [Abstract][Full Text] [Related]
4. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Srinivasan J; Schmidt WJ
Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
[TBL] [Abstract][Full Text] [Related]
5. Effect of PACAP in 6-OHDA-induced injury of the substantia nigra in intact young and ovariectomized female rats.
Reglödi D; Lubics A; Kiss P; Lengvári I; Gaszner B; Tóth G; Hegyi O; Tamás A
Neuropeptides; 2006 Aug; 40(4):265-74. PubMed ID: 16904179
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.
Reglodi D; Lubics A; Tamás A; Szalontay L; Lengvári I
Behav Brain Res; 2004 May; 151(1-2):303-12. PubMed ID: 15084446
[TBL] [Abstract][Full Text] [Related]
7. Partial loss of dopaminergic neurons in the substantia nigra, ventrotegmental area and the retrorubral area -- model of the early beginning of Parkinson's symptomatology?
Heim C; Sova L; Kurz T; Kolasiewicz W; Schwegler H; Sontag KH
J Neural Transm (Vienna); 2002 May; 109(5-6):691-709. PubMed ID: 12111461
[TBL] [Abstract][Full Text] [Related]
8. Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease.
Rodríguez M; Barroso-Chinea P; Abdala P; Obeso J; González-Hernández T
Exp Neurol; 2001 May; 169(1):163-81. PubMed ID: 11312569
[TBL] [Abstract][Full Text] [Related]
9. Intrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's Disease.
Boronat-García A; Palomero-Rivero M; Guerra-Crespo M; Millán-Aldaco D; Drucker-Colín R
PLoS One; 2016; 11(8):e0160854. PubMed ID: 27525967
[TBL] [Abstract][Full Text] [Related]
10. Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease.
Vercammen L; Van der Perren A; Vaudano E; Gijsbers R; Debyser Z; Van den Haute C; Baekelandt V
Mol Ther; 2006 Nov; 14(5):716-23. PubMed ID: 16914382
[TBL] [Abstract][Full Text] [Related]
11. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
[TBL] [Abstract][Full Text] [Related]
12. Reductions in spontaneous locomotor activity in aged male, but not female, rats in a model of early Parkinson's disease.
Cass WA; Peters LE; Smith MP
Brain Res; 2005 Feb; 1034(1-2):153-61. PubMed ID: 15713267
[TBL] [Abstract][Full Text] [Related]
13. Bilobalide inhibits 6-OHDA-induced activation of NF-kappaB and loss of dopaminergic neurons in rat substantia nigra.
Li LY; Zhao XL; Fei XF; Gu ZL; Qin ZH; Liang ZQ
Acta Pharmacol Sin; 2008 May; 29(5):539-47. PubMed ID: 18430361
[TBL] [Abstract][Full Text] [Related]
14. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
Dabbeni-Sala F; Di Santo S ; Franceschini D; Skaper SD; Giusti P
FASEB J; 2001 Jan; 15(1):164-170. PubMed ID: 11149904
[TBL] [Abstract][Full Text] [Related]
15. Effects of aging and gender on striatal and extrastriatal [123I]FP-CIT binding in Parkinson's disease.
Kaasinen V; Joutsa J; Noponen T; Johansson J; Seppänen M
Neurobiol Aging; 2015 Apr; 36(4):1757-1763. PubMed ID: 25697414
[TBL] [Abstract][Full Text] [Related]
16. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
Ogura T; Ogata M; Akita H; Jitsuki S; Akiba L; Noda K; Hoka S; Saji M
Neurosci Res; 2005 Mar; 51(3):299-308. PubMed ID: 15710494
[TBL] [Abstract][Full Text] [Related]
17. Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion.
Kikuchi Y; Yasuhara T; Agari T; Kondo A; Kuramoto S; Kameda M; Kadota T; Baba T; Tajiri N; Wang F; Tayra JT; Liang H; Miyoshi Y; Borlongan CV; Date I
J Cell Physiol; 2011 May; 226(5):1390-8. PubMed ID: 20945350
[TBL] [Abstract][Full Text] [Related]
18. [The protective effect of ginsenoside Rg1 on dopaminergic neurons of substantia in the ovariectomized rat model of Parkinson's disease].
Xu L; Liu LX; Chen WF; Xie JX; Huang WX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):1-5. PubMed ID: 21141541
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of BDNF in young and aged 6-OHDA treated rat model of Parkinson disease.
Singh S; Ahmad R; Mathur D; Sagar RK; Krishana B
Indian J Exp Biol; 2006 Sep; 44(9):699-704. PubMed ID: 16999024
[TBL] [Abstract][Full Text] [Related]
20. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.
Liu CQ; Chen Z; Liu FX; Hu DN; Luo JH
Neuropharmacology; 2007 Dec; 53(7):832-41. PubMed ID: 17919665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]